James J Lynch MD LTD
James J Lynch MD LTD was paid $1.03M by Medicaid between Jan 2018 and Dec 2024, across 34 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 52% of everything it billed.
33Billing provider infoJAMES J LYNCH MD LTD
RENO, NV 89521
RENO, NV 89521
33aNPI1285649608assigned 07/31/2006
33bProvider typeSpecialist
28Total paid$1.03M
24GClaims29,083
24DCodes billed34
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Nevada
Rank by total paid#12 of 98
Median peer was paid$76K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,771 | $49K | |
| 2019 | 4,100 | $125K | |
| 2020 | 2,331 | $99K | |
| 2021 | 3,544 | $137K | |
| 2022 | 6,670 | $187K | |
| 2023 | 5,923 | $224K | |
| 2024incomplete | 4,744 | $212K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 52% | 12,808 | 11,290 | $536K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 4,147 | 3,605 | $152K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.2% | 929 | 758 | $54K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 4.9% | 612 | 535 | $51K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.7% | 1,684 | 610 | $48K |
| 93970 | 4.6% | 514 | 433 | $48K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.9% | 1,773 | 639 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.3% | 1,393 | 1,219 | $24K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.0% | 1,372 | 531 | $21K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.0% | 243 | 226 | $21K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1.3% | 305 | 245 | $14K |
| 73630 | <1% | 517 | 357 | $8K |
22 more codes
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 932 | $4K |
| 99152 | <1% | 147 | $4K | |
| 64483 | <1% | 42 | $4K | |
| 20610 | <1% | 101 | $2K | |
| 73564 | <1% | 58 | $2K | |
| 20611 | <1% | 30 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $2K |
| 20553 | <1% | 69 | $1K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 149 | $1K |
| 64493 | <1% | 13 | $1K | |
| 72110 | <1% | 42 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 19 | $948.75 |
| 73030 | <1% | 30 | $808.73 | |
| 64494 | <1% | 13 | $592.76 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 27 | $588.30 |
| 81000 | <1% | 649 | $392.62 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 364 | $321.52 |
| 20550 | <1% | 15 | $103.04 | |
| 96127 | <1% | 18 | $36.98 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 20 | $4.49 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 15 | $1.01 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 20 | $0.10 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLYNCH, JAMES (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Rochester Colon & Rectal, P.C. | Rochester Hills, MI | $242K |
| Lynch Family Chiropractic LLC | Montpelier, VT | $81K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.